4/A
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-22-000050
Chief Executive Officer sold 9,718 shares at $2.03 ($19,706)
From the SEC's structured data for this filing
Trades in this filing
Hively Brad · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-15 | Sale : show line 1 in the form | −9,718 | $2.03 | $19,706 | 452,201 | D |
| Open-market sales · 9,718 sh · avg $2.03 · $19,706 | ||||||
Loading xslF345X03/edgardoc.xml…